Gul Erdemli

Company: Novartis AG

Job title: Director - Global Program Regulatory

Seminars:

Panel Discussion: What are the Current Unmet Needs in Tackling Neurological Diseases that Digital Biomarkers can Fill? 9:30 am

Improving the ability to both identify neurological diseases earlier in the disease process and monitor disease progression using novel digital biomarkers In what types of neurological indications have digital measures seen the best success so far? Outlining strategies for digital biomarker implementation into established clinical trial proceduresRead more

day: Conference Day One